1. Immune status and cancer chemotherapy efficacy

   • G. Mathé

   Editorial Pages: 81 - 83

2. Human chorionic gonadotropin: Doubtful role as an inhibitor of cell-mediated immunity

   • M. A. Bean
   • J. S. Salser
   • M. E. Balis

   Original Papers Pages: 85 - 90

3. In vitro induction of tumor-specific immunity. IV. Specific adoptive immunotherapy with cytotoxic T cells induced in vitro to plasmacytoma antigens

   • Robert C. Burton
   • Noel L. Warner

   Original Papers Pages: 91 - 99

4. Differential responsiveness of various substrains of inbred strain 2 guinea pigs to immunotherapy with the methanol extraction residue (MER) of BCG

   • Mark A. Wainberg
   • Richard G. Margolese
   • David W. Weiss

   Original Papers Pages: 101 - 108

5. Serological changes in adjuvant-treated mice, their specificity and relevance to tumor immunity

   • K. James
   • N. Willmott
   • R. Cullen

   Original Papers Pages: 109 - 117

6. Effect of treatment with dimethyl triazeno imidazole carboxamide (DTIC, NSC-45388) or 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) plus vincristine (NSC-67574) on lymphocyte reactivity of melanoma patients

   • Jane Berkelhammer
   • Michael J. Mastrangelo
   • Richmond T. Prehn

   Original Papers Pages: 119 - 125

7. Immunogenicity of “viable” tumor cells after storage in liquid nitrogen

   • G. L. Bartlett
   • D. C. Katsilas
   • D. M. Purnell

   Original Papers Pages: 127 - 133

8. A new assay for cell-bound neuraminidase

   • M. Petitou
   • C. Rosenfeld
   • P. Sinay

   Original Papers Pages: 135 - 137

9. Effectiveness of murine leukemia chemotherapy according to the immune state

   • G. Mathé
   • O. Halle-Pannenko
   • C. Bourut

   Short Communications Pages: 139 - 141

10. Immunotherapy of a guinea pig hepatoma with ultrasonically prepared mycobacterial vaccines

    • E. Yarkoni
    • H. J. Rapp
    • B. Zbar

    Short Communications Pages: 143 - 146